We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




New Bacterial Target Identified for Early Detection of Noma

By LabMedica International staff writers
Posted on 01 Apr 2026

Noma is a rapidly progressing orofacial infection that begins as gingivitis and can destroy oral and facial tissues, primarily affecting young children living in extreme poverty. More...

Without treatment, it is fatal in up to 90% of cases, and survivors face severe disfigurement and lifelong complications. Most cases are identified too late, when significant tissue damage has already occurred. Researchers now report a microbial discovery that could enable earlier diagnosis and more effective treatment.

Liverpool School of Tropical Medicine (LSTM) researchers, working with the University of Liverpool, Médecins Sans Frontières, and the Noma Children’s Hospital in Sokoto, Nigeria, applied shotgun metagenomic sequencing and machine-learning algorithms to saliva samples from children with acute noma. The analyses uncovered a previously undescribed Treponema species that was strongly associated with the disease. Treponema bacteria were also detected in early disease stages, suggesting they may play a key role in triggering progression from gingivitis to noma.

Further analysis indicated the identified bacteria did not harbor known antibiotic resistance genes, implying potential susceptibility to existing antibiotic treatments when detected early. The investigators also observed a disrupted oral microbiome in affected children, with Treponema taxa appearing more common and bacteria typical of a healthy mouth diminished. Together, these findings point to a consistent microbial signature for noma that could support earlier detection.

The research is published in PLOS Neglected Tropical Diseases. Noma was formally classified as a neglected tropical disease by the World Health Organization in 2023. According to the team, the discovery opens a path toward diagnostic tools that can identify the disease at its earliest stages, when treatment is most effective. The identification of a consistent microbial pattern marks a step forward in understanding this long-neglected condition and brings renewed hope for prevention, diagnosis, and treatment.

“We found that the composition of bacteria in children with noma is completely disrupted. Some bacteria, such as those in the Treponema genus, appear to be more common, while others that are usually part of a healthy mouth almost disappear. That imbalance gives us important clues about how the disease starts and progresses,” said Richard Goodman, joint lead author at Liverpool School of Tropical Medicine.

“Noma is a disease that simply should not exist, but up until now we have lacked a detailed understanding of the microbes involved. By using metagenomic sequencing, we can now see the full bacterial community in unprecedented detail. This has allowed us to identify a species of Treponema bacteria strongly linked to the disease,” said Adam Roberts, Professor at the Liverpool School of Tropical Medicine’s Center for Neglected Tropical Diseases.

Related Links
Liverpool School of Tropical Medicine (LSTM)


Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Online QC Software
Acusera 24•7
LAIR2 Antibody Pair Set
LAIR2 Antibody Pair [Biotin]
Japanese Encephalitis Test
Japanese Encephalitis Virus Real Time PCR Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The approach supports myocardial infarction diagnosis in resource-limited settings by reducing delays between clinical suspicion and biochemical confirmation (Image Credit: Adobe Stock)

Portable Troponin Assay Brings Heart Attack Diagnosis Closer to Patients

Timely confirmation of myocardial infarction often depends on laboratory testing that may not be immediately available at the point of care. This gap between clinical suspicion and definitive evidence... Read more

Molecular Diagnostics

view channel
Image: The platform analyzes cell-free DNA in blood, searching for minute amounts of tumor-derived fragments among background DNA (Image Credit: Adobe Stock)

Blood Test Could Help Fast-Track Lymphoma Diagnosis in Resource-Limited Settings

Lymphoma can be difficult to distinguish from infections and benign conditions, while definitive diagnosis often depends on surgical tissue sampling and specialized pathology that may not be readily available.... Read more

Pathology

view channel
Image: Through the PCCP, Proscia gains a more efficient pathway to expand Concentriq AP-Dx interoperability while maintaining regulatory oversight (Photo courtesy of Proscia)

FDA-Cleared Digital Pathology Platform Expands Interoperability for Primary Diagnosis

Rising cancer incidence is colliding with a shrinking pathologist workforce, intensifying pressure on diagnostic turnaround times in clinical laboratories. Many labs are adopting digital pathology to manage... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.